Established in 1958, ASH is the world’s largest professional organization for clinicians and scientists who study blood diseases. 

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.

In a large, placebo-controlled, randomized trial, the pain reliever ketamine posed side effects while failing to aid patient recovery after major surgery.

Study showed that the improvement in lung cancer screenings exceeded the target enrollment set by the researchers.

Researchers hope to slow the progression of this chronic eye disease that affects approximately 40% of the U.S. population.

Using molecular and other data from both the bacterial and human sides of the equation, a multi-institutional team will develop prediction models of TB transmission.